Divergent backward masking performance in schizophrenia and bipolar disorder: Association with COMT

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 2, 2008, Pages 223-227

  Goghari, Vina M ^a   Sponheim, Scott R ^a,b,c,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VA MEDICAL CENTER   (United States)

Author keywords

Attention; Bipolar disorder; Catechol O methyl transferase Val108 158Met; Masking; Schizophrenia; Visual processing

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; BIPOLAR DISORDER; CATECHOLAMINE METHYLTRANSFERASE GENE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; GENE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; VISION; VISUAL MASKING; WORKING MEMORY;

EID: 40449112689     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30583     Document Type: Article

References (26)

1. Badner JA, Gershon ES. 2002. Meta‐analysis of whole‐genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7: 405–411.
2. Bergman‐Jungestrom M, Wingren S. 2001. Catechol‐O‐Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Br J Cancer 85: 859–862.
3. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X, Goldman RS, Hoptman MJ, Sheitman B, Lindenmayer JP, et al. 2002. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52: 701–707.
4. Booker BH, Cyr JJ. 1986. Tables for clinicians to use to convert WAIS‐R short forms. J Clin Psychol 42: 983.
5. Burger GK, Calsyn RJ, Morse GA, Klinkenberg WD, Trusty ML. 1997. Factor structure of the expanded brief psychiatric rating scale. J Clin Psychol 53: 451–454.
6. Gottesman II, Gould TD. 2003. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 160: 636–645.
7. Green MF, Nuechterlein KH, Breitmeyer B. 2002. Development of a computerized assessment for visual masking. Int J Methods Psychiatr Res 11: 83–89.
8. Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. 2006. Forward and backward visual masking in unaffected siblings of schizophrenic patients. Biol Psychiatry 59: 446–451.
9. Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS. 2007. The consortium on the genetics of schizophrenia: Neurocognitive endophenotypes. Schizophr Bull 33: 49–68.
10. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10: 40–68.
11. Keri S, Kelemen O, Benedek G, Janka Z. 2001. Different trait markers for schizophrenia and bipolar disorder: A neurocognitive approach. Psychol Med 31: 915–922.
12. MacQueen GM, Young LT, Galway TM, Joffe RT. 2001. Backward masking task performance in stable, euthymic out‐patients with bipolar disorder. Psychol Med 31: 1269–1277.
13. MacQueen GM, Grof P, Alda M, Marriott M, Young LT, Duffy A. 2004. A pilot study of visual backward masking performance among affected versus unaffected offspring of parents with bipolar disorder. Bipolar Disord 6: 374–478.
14. McClure RK. 1999. Backward masking in bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry 23: 195–206.
15. McClure RK. 2001. The visual backward masking deficit in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 25: 301–311.
16. Raine A. 1991. The SPQ: A scale for the assessment of schizotypal personality based on DSM‐III‐R criteria. Schizophr Bull 17: 555–564.
17. Ramachandran VS, Cobb S. 1995. Visual attention modulates metacontrast masking. Nature 373: 66–68.
18. Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J. 2005. Modulation of attention during visual masking in schizophrenia. Am J Psychiatry 162: 1533–1535.
19. Saccuzzo DP, Schubert DL. 1981. Backward masking as a measure of slow processing in schizophrenia spectrum disorders. J Abnorm Psychol 90: 305–312.
20. Schott BH, Seidenbecher CI, Fenker DB, Lauer CJ, Bunzeck N, Bernstein HG, Tischmeyer W, Gundelfinger ED, Heinze HJ, Duzel E. 2006. The dopaminergic midbrain participates in human episodic memory formation: Evidence from genetic imaging. J Neurosci 26: 1407–1417.
21. Snitz BE, Macdonald AW IIIrd, Carter CS. 2006. Cognitive deficits in unaffected first‐degree relatives of schizophrenia patients: A meta‐analytic review of putative endophenotypes. Schizophr Bull 32: 179–194.
22. Sponheim SR, Steele VR, McGuire KA. 2004. Verbal memory processes in schizophrenia patients and biological relatives of schizophrenia patients: Intact implicit memory, impaired explicit recollection. Schizophr Res 71: 339–348.
23. Sponheim SR, McGuire KA, Stanwyck JJ, Bender T, Malone SM. 2006. The COMT val allele is associated with diminished neural responses in schizophrenia patients and their relatives during sustained attention. 20th Annual Meeting for the Society for Research in Psychopathology; San Diego, California.
24. Thaker GK, Wonodi I, Avila MT, Hong LE, Stine OC. 2004. Catechol O‐methyltransferase polymorphism and eye tracking in schizophrenia: A preliminary report. Am J Psychiatry 161: 2320–2322.
25. Ventura J, Lukoff D, Nuechterlein KH, Liberman RP, Green MF, Shaner A. 1993. Manual for the expanded brief psychiatric rating scale. Int J Methods Psychiatr Res 3: 221–224.
26. Weissman MM. 1978. Social Adjustment Scale‐II. New Haven: Depression Research Unit, Connecticut Mental Health Center.